Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Skyward Specialty Insurance Group, Inc. insiders sold a net $371.0K of stock across 100 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Nobody has filed for crossing 5%. That is a fact, not missing data.
SKWD planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
SKWD mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Porter & Company Porter Portfolio Index ETF
$660.3K position · as of 2026-06-30
5.6%
Reinhart Genesis PMV Fund
$22.6M position · as of 2026-05-31
3.2%
F/m Emerald Special Situations ETF
$906.8K position · as of 2026-07-31
2.7%
Wasatch Micro Cap Value Fund
$9.9M position · as of 2026-06-30
2.6%
abrdn Focused U.S. Small Cap Active ETF
$223.8K position · as of 2026-07-31
2.2%
State Street(R) SPDR(R) S&P(R) Insurance ETF
$9.8M position · as of 2026-06-30
2.1%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Mr. Robinson
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$5.5M
$6.1M
$1.4M
+168%
+28%
2024
$4.6M
$17.1M
$1.1M
+165%
+28%
2023
$8.6M
$23.2M
$1.7M
+77%
+3%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $371.0K sold by insiders over 180 days, 136 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.7B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM SKWD
FY Dec 2025
$1.4B
FY Dec 2024
$1.2B
FY Dec 2023
$886.0M
FY Dec 2022
$642.4M
FY Dec 2021
n/a
Jun 2026
$489.5M
Mar 2026
$475.9M
Dec 2025
$385.6M
Sep 2025
$382.5M
Jun 2025
$319.9M
Mar 2025
$328.5M
Dec 2024
$304.4M
Sep 2024
$300.9M
At each fiscal year end
Single quarter
Net margin, TTM
+10.8%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM SKWD
FY Dec 2025
+12.0%
FY Dec 2024
+10.3%
FY Dec 2023
+9.7%
FY Dec 2022
+6.1%
FY Dec 2021
n/a
Jun 2026
+10.0%
Mar 2026
+10.5%
Dec 2025
+11.2%
Sep 2025
+12.0%
Jun 2025
+12.1%
Mar 2025
+12.8%
Dec 2024
+4.7%
Sep 2024
+12.2%
At each fiscal year end
Single quarter
Free cash flow, TTM
$401.8M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM SKWD
FY Dec 2025
$402.6M
FY Dec 2024
$300.9M
FY Dec 2023
$335.1M
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
$50.1M
Sep 2025
$168.9M
Jun 2025
$87.1M
Mar 2025
$96.6M
Dec 2024
$20.8M
Sep 2024
$167.6M
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity SKWD
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt SKWD
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+17.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity SKWD
FY Dec 2025
+18.9%
FY Dec 2024
+16.3%
FY Dec 2023
+15.9%
FY Dec 2022
+9.3%
FY Dec 2021
n/a
Jun 2026
+17.3%
Mar 2026
+17.1%
Dec 2025
+18.9%
Sep 2025
+16.1%
Jun 2025
+16.3%
Mar 2025
+16.1%
Dec 2024
+16.3%
Sep 2024
+20.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+3.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets SKWD
FY Dec 2025
+4.0%
FY Dec 2024
+3.6%
FY Dec 2023
+3.2%
FY Dec 2022
+1.8%
FY Dec 2021
n/a
Jun 2026
+3.4%
Mar 2026
+3.4%
Dec 2025
+4.0%
Sep 2025
+3.4%
Jun 2025
+3.4%
Mar 2025
+3.4%
Dec 2024
+3.6%
Sep 2024
+4.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital SKWD
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed SKWD
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
13.98x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing SKWD
FY Dec 2025
12.53x
FY Dec 2024
17.55x
FY Dec 2023
15.13x
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
13.57x
Mar 2026
10.50x
Dec 2025
12.53x
Sep 2025
14.07x
Jun 2025
18.23x
Mar 2025
17.70x
Dec 2024
17.55x
Sep 2024
12.42x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value SKWD
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+15.1%
TTM free cash flow over market value at close 2026-10-26
FCF yield SKWD
FY Dec 2025
+19.5%
FY Dec 2024
+14.8%
FY Dec 2023
+26.2%
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
+17.0%
Mar 2026
+21.7%
Dec 2025
+19.5%
Sep 2025
+19.4%
Jun 2025
+15.9%
Mar 2025
+14.3%
Dec 2024
+14.8%
Sep 2024
+24.3%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.39x
P/E over trailing EPS growth of 36%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing SKWD
FY Dec 2025
0.30x
FY Dec 2024
0.61x
FY Dec 2023
0.16x
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
0.38x
Mar 2026
0.27x
Dec 2025
0.30x
Sep 2025
4.62x
Jun 2025
2.57x
Mar 2025
1.78x
Dec 2024
0.61x
Sep 2024
0.23x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
SKWD ranks highest on insider conviction (66th percentile) and growth (63rd), and lowest on risk and compliance (34th), among Insurance peers.
Profitability
57
Inputs
Return on equity+17.3% · 59 pct, sector of 116
Return on assets+3.4% · 55 pct, sector of 122
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Growth
63
Inputs
Revenue growth, YoY+16.0% · 63 pct, sector of 134
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
66
Inputs
Net Form 4 buying (codes P and S), 180d-$371K · 70 pct, sector of 100
Insider buyers, 180d1 · 62 pct, sector of 101
Institutional and government
59
Inputs
Funds adding, latest quarter136 · 45 pct, sector of 108
Congress net buyers, 365d1 · 73 pct, universe of 719
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
34
Inputs
Short interest, % of float+4.8% · 35 pct, sector of 138
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-K+14.0% · 32 pct, sector of 110
2 not measured: Financial health, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
SKWD filings, in plain words
Are Skyward Specialty Insurance insiders buying or selling SKWD?
In the 180 days to 2026-10-28, Skyward Specialty Insurance insiders were net sellers, a net $371.0K: $94.2K of purchases and $465.2K of sales reported on Form 4, by 1 buyer and 2 sellers.
Have members of Congress traded SKWD?
Yes. In the year to 2026-10-28, 1 House member disclosed buying SKWD and 0 House members disclosed selling it; the latest on record is a purchase by Gilbert Cisneros dated 2026-07-16.
Read the full summary
In the 180 days to 2026-10-28, Skyward Specialty Insurance insiders were net sellers of SKWD, a net $371.0K across purchases and sales reported on Form 4 by 1 buyer and 2 sellers. None of the 4 insider sales was flagged as made under a Rule 10b5-1 plan. In the year to 2026-10-28, 1 member of Congress disclosed buying SKWD and 0 members disclosed selling it; the latest on record is a purchase by Gilbert Cisneros dated 2026-07-16. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.